Libo Chen
Impact in
- Immunology top 10%
- Galectins and Cancer Biology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hepatology top 5%
Papers in
-
- Epigenetics and DNA Methylation 2
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Guobin Wang (5 shared papers)Xiaoming Lu (1 shared paper)Kaixiong Tao (1 shared paper)Hang Li (1 shared paper)Qichang Zheng (1 shared paper)Weiping Zou (1 shared paper)Liang Shi (1 shared paper)Ke Wu (2 shared papers)
- Journals
- Toxics (2 papers)International Immunopharmacology (1 paper)Frontiers in Oncology (1 paper)Polymer Engineering and Science (1 paper)Cancer Control (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Libo Chen
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 88
- Immunology 360
- Hepatology 104
- Genetics 136
- Oncology 328
- Cancer Research 166
Countries citing papers authored by Libo Chen
This map shows the geographic impact of Libo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Chen more than expected).
Fields of papers citing papers by Libo Chen
This network shows the impact of papers produced by Libo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Chen. The network helps show where Libo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 416 | |
| 2 | 2004 | 242 | |
| 3 | 2010 | 85 | |
| 4 | 2016 | 84 | |
| 5 | 2021 | 49 | |
| 6 | Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene. | 2006 | 43 |
| 7 | 2011 | 35 | |
| 8 | 2008 | 33 | |
| 9 | 2021 | 25 | |
| 10 | 2012 | 24 | |
| 11 | 2021 | 21 | |
| 12 | 2001 | 21 | |
| 13 | 2006 | 20 | |
| 14 | 2020 | 15 | |
| 15 | 2009 | 14 | |
| 16 | 2017 | 14 | |
| 17 | 2010 | 14 | |
| 18 | 2021 | 14 | |
| 19 | 2021 | 13 | |
| 20 | 2017 | 12 |
About Libo Chen
Libo Chen is a scholar working on Molecular Biology, Immunology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Cell Adhesion Molecules Research (3 papers), MicroRNA in disease regulation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Testicular diseases and treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Immunology (360 citations), Hepatology (104 citations), Genetics (136 citations), Oncology (328 citations) and Cancer Research (166 citations). Libo Chen has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Guobin Wang, Xiaoming Lu, Kaixiong Tao, Hang Li, Qichang Zheng, Weiping Zou, Liang Shi, Ke Wu, Jun Liu and Lian Yang. Their work appears in journals such as Toxics, International Immunopharmacology, Frontiers in Oncology, Polymer Engineering and Science and Cancer Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.